CLOV vs EBS
Clover Health Investments Corp (CLOV) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CLOV currently screens at market cap $1.55B. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CLOV and EBS stock pages for the full models.
Not investment advice.